POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 94 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,746 | +40.3% | 91,490 | +3.8% | 0.00% | – |
| Q2 2023 | $155,179 | -92.3% | 88,170 | -86.5% | 0.00% | – |
| Q1 2023 | $2,006,294 | +39.2% | 651,394 | +139.5% | 0.00% | – |
| Q4 2022 | $1,441,473 | +88.2% | 271,976 | +25.3% | 0.00% | – |
| Q3 2022 | $766,000 | +233.0% | 217,001 | +543.4% | 0.00% | – |
| Q4 2021 | $230,000 | +75.6% | 33,726 | +87.4% | 0.00% | – |
| Q3 2021 | $131,000 | -14.4% | 18,000 | +17.6% | 0.00% | – |
| Q2 2021 | $153,000 | -67.0% | 15,300 | -68.4% | 0.00% | – |
| Q1 2021 | $463,000 | – | 48,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
| Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
| Atom Investors LP | 156,168 | $371,680 | 0.08% |
| Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
| Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
| Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
| XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
| Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
| RBF Capital, LLC | 70,171 | $167,007 | 0.01% |